Literature DB >> 28348039

What Is the Predictive Value of Animal Models for Vaccine Efficacy in Humans? Reevaluating the Potential of Mouse Models for the Human Immune System.

Stephen C Jameson1, David Masopust1.   

Abstract

Much of what we understand about immunology, including the response to vaccines, come from studies in mice because they provide many practical advantages compared with research in higher mammals and humans. Nevertheless, modalities for preventing or treating disease do not always translate from mouse to humans, which has led to increasing scrutiny of the continued merits of mouse research. Here, we summarize the pros and cons of current laboratory mouse models for immunology research and discuss whether overreliance on nonphysiological, ultra-hygienic animal husbandry approaches has limited the ultimate translation potential of mouse-derived data to humans. Alternative approaches are discussed that may extend the use of the mouse model for preclinical studies.
Copyright © 2018 Cold Spring Harbor Laboratory Press; all rights reserved.

Entities:  

Mesh:

Substances:

Year:  2018        PMID: 28348039      PMCID: PMC5880167          DOI: 10.1101/cshperspect.a029132

Source DB:  PubMed          Journal:  Cold Spring Harb Perspect Biol        ISSN: 1943-0264            Impact factor:   10.005


  44 in total

1.  Dietary antigens limit mucosal immunity by inducing regulatory T cells in the small intestine.

Authors:  Kwang Soon Kim; Sung-Wook Hong; Daehee Han; Jaeu Yi; Jisun Jung; Bo-Gie Yang; Jun Young Lee; Minji Lee; Charles D Surh
Journal:  Science       Date:  2016-01-28       Impact factor: 47.728

Review 2.  Childhood undernutrition, the gut microbiota, and microbiota-directed therapeutics.

Authors:  Laura V Blanton; Michael J Barratt; Mark R Charbonneau; Tahmeed Ahmed; Jeffrey I Gordon
Journal:  Science       Date:  2016-06-24       Impact factor: 47.728

Review 3.  Concepts and ways to amplify the antitumor immune response.

Authors:  Bent Rubin; Jean Edouard Gairin
Journal:  Curr Top Microbiol Immunol       Date:  2011       Impact factor: 4.291

4.  Protective immunity produced by the injection of x-irradiated sporozoites of plasmodium berghei.

Authors:  R S Nussenzweig; J Vanderberg; H Most; C Orton
Journal:  Nature       Date:  1967-10-14       Impact factor: 49.962

5.  The rise and fall of the CD28 superagonist TGN1412 and its return as TAB08: a personal account.

Authors:  Thomas Hünig
Journal:  FEBS J       Date:  2016-06-06       Impact factor: 5.542

Review 6.  Of mice and not men: differences between mouse and human immunology.

Authors:  Javier Mestas; Christopher C W Hughes
Journal:  J Immunol       Date:  2004-03-01       Impact factor: 5.422

7.  Herpesvirus latency confers symbiotic protection from bacterial infection.

Authors:  Erik S Barton; Douglas W White; Jason S Cathelyn; Kelly A Brett-McClellan; Michael Engle; Michael S Diamond; Virginia L Miller; Herbert W Virgin
Journal:  Nature       Date:  2007-05-17       Impact factor: 49.962

Review 8.  Interactions of commensal gut microbes with subsets of B- and T-cells in the murine host.

Authors:  H-Q Jiang; M C Thurnheer; A W Zuercher; N V Boiko; N A Bos; J J Cebra
Journal:  Vaccine       Date:  2004-02-17       Impact factor: 3.641

9.  Development and function of human innate immune cells in a humanized mouse model.

Authors:  Anthony Rongvaux; Tim Willinger; Jan Martinek; Till Strowig; Sofia V Gearty; Lino L Teichmann; Yasuyuki Saito; Florentina Marches; Stephanie Halene; A Karolina Palucka; Markus G Manz; Richard A Flavell
Journal:  Nat Biotechnol       Date:  2014-03-16       Impact factor: 54.908

Review 10.  Blowing on embers: commensal microbiota and our immune system.

Authors:  Darina S Spasova; Charles D Surh
Journal:  Front Immunol       Date:  2014-07-28       Impact factor: 7.561

View more
  6 in total

1.  Modeling human adaptive immune responses with tonsil organoids.

Authors:  Lisa E Wagar; Ameen Salahudeen; Christian M Constantz; Ben S Wendel; Michael M Lyons; Vamsee Mallajosyula; Lauren P Jatt; Julia Z Adamska; Lisa K Blum; Neha Gupta; Katherine J L Jackson; Fan Yang; Katharina Röltgen; Krishna M Roskin; Kelly M Blaine; Kara D Meister; Iram N Ahmad; Mario Cortese; Emery G Dora; Sean N Tucker; Anne I Sperling; Aarti Jain; D Huw Davies; Philip L Felgner; Gregory B Hammer; Peter S Kim; William H Robinson; Scott D Boyd; Calvin J Kuo; Mark M Davis
Journal:  Nat Med       Date:  2021-01-11       Impact factor: 53.440

2.  Mice with diverse microbial exposure histories as a model for preclinical vaccine testing.

Authors:  Jessica K Fiege; Katharine E Block; Mark J Pierson; Hezkiel Nanda; Frances K Shepherd; Clayton K Mickelson; J Michael Stolley; William E Matchett; Sathi Wijeyesinghe; David K Meyerholz; Vaiva Vezys; Steven S Shen; Sara E Hamilton; David Masopust; Ryan A Langlois
Journal:  Cell Host Microbe       Date:  2021-11-02       Impact factor: 21.023

3.  Plasma levels of serum amyloid A1 and mortality after exposure to high-dose radiation.

Authors:  Dmitry Klokov
Journal:  Ann Transl Med       Date:  2020-06

4.  Engineering a vector-based pan-Leishmania vaccine for humans: proof of principle.

Authors:  Pedro Cecílio; James Oristian; Claudio Meneses; Tiago D Serafim; Jesus G Valenzuela; Anabela Cordeiro da Silva; Fabiano Oliveira
Journal:  Sci Rep       Date:  2020-10-29       Impact factor: 4.996

Review 5.  In vitro high-content tissue models to address precision medicine challenges.

Authors:  Samson Afewerki; Thiago Domingues Stocco; André Diniz Rosa da Silva; André Sales Aguiar Furtado; Gustavo Fernandes de Sousa; Guillermo U Ruiz-Esparza; Thomas J Webster; Fernanda R Marciano; Maria Strømme; Yu Shrike Zhang; Anderson Oliveira Lobo
Journal:  Mol Aspects Med       Date:  2022-08-17

Review 6.  Human Organoids and Organs-on-Chips for Addressing COVID-19 Challenges.

Authors:  Yaqing Wang; Peng Wang; Jianhua Qin
Journal:  Adv Sci (Weinh)       Date:  2022-02-02       Impact factor: 16.806

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.